• Cyanidin Chloride: Advancing Antioxidant Research in Skin Di

  2026-07-15

  This thought-leadership article explores Cyanidin Chloride, an anthocyanin polyphenolic antioxidant from Bilberry, as a next-generation tool for oxidative stress and inflammation research. Integrating mechanistic insights and strategic lab guidance, it examines recent evidence of barrier restoration and cytokine regulation in psoriasis models, outlines practical workflow parameters, and critically evaluates the translational landscape. By bridging recent findings with actionable recommendations, the article delivers novel perspective for researchers aiming to translate cellular antioxidant mechanisms into clinically relevant endpoints.

• Temafloxacin: In Vitro Activity, Pharmacokinetics, and Tissu

  2026-07-15

  This study rigorously characterizes the in vitro antibacterial spectrum, pharmacokinetics, and tissue distribution of temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent. Its efficacy against key Gram-positive, Gram-negative, and atypical pathogens, coupled with favorable pharmacokinetics, positions it as a valuable reference compound for infection modeling and antibacterial assay development.

• Bazedoxifene: Advanced Mechanistic Insights for Osteoporosis

  2026-07-14

  Explore the unique pharmacology of Bazedoxifene, a selective estrogen receptor modulator, with a focus on its implications for bone mineral density enhancement and translational osteoporosis treatment research. This article delivers new perspectives on assay design and clinical relevance.

• Regorafenib (BAY 73-4506): Applied Protocols in Cancer Biolo

  2026-07-14

  Regorafenib (BAY 73-4506) empowers researchers with precise multikinase inhibition, enabling advanced angiogenesis and tumor biology workflows. Recent breakthroughs in melanoma research spotlight its unique ability to suppress malignancy via RRM2 downregulation and ERK/E2F3 pathway modulation.

• RSV NS3 Modulates Host Kinase Pathways to Balance Pathogenic

  2026-07-13

  Zhuang et al. (2025) uncover how Rice stripe virus (RSV) NS3 manipulates host kinase signaling, specifically the OsSnRK3.25-OsCBL1/3-OsRBOHF axis, to fine-tune viral pathogenicity and transmission. These findings reveal a dynamic co-survival strategy and provide a detailed mechanistic framework for understanding virus-host-vector interactions in plant pathology.

• Transmission Dynamics of Carbapenemase Genes in CREC During

  2026-07-13

  This study provides the first in-depth analysis of carbapenemase-encoding gene (CEG) prevalence and plasmid-mediated transmission in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals during the COVID-19 pandemic. Findings highlight the dominance of blaNDM-1, high multidrug resistance, and the significant role of mobile genetic elements, informing future research on antimicrobial resistance and hospital infection control.

• Practical Guidance for Using CUDC-907: Dual PI3K and HDAC In

  2026-07-12

  CUDC-907 offers researchers a validated tool for simultaneous inhibition of PI3K/AKT and HDAC pathways in established cancer cell models. It is suitable for in vitro workflows focused on mechanistic studies of cell signaling, cell cycle arrest, and apoptosis, but is not intended for diagnostic or clinical applications.

• Aztreonam in Multidrug Resistance Research: New Mechanistic

  2026-07-10

  Explore Aztreonam as a monocyclic β-lactam antibiotic with unique properties for multidrug resistance research. This article delivers fresh insight into transmission dynamics, pharmacological implications, and cutting-edge protocol guidance.

• Aztreonam: Transforming Gram-Negative Research & Strategy

  2026-07-09

  Explore how Aztreonam, the first synthetic monocyclic β-lactam antibiotic, is redefining translational research on Gram-negative bacteria. This thought-leadership article synthesizes mechanistic insights, recent in vitro resistance breakthroughs, and actionable protocol parameters, offering strategic guidance for experimentalists navigating the dual challenges of bacterial resistance and metabolic complexity. Contextual evidence, competitive analysis, and APExBIO’s product quality converge to provide a forward-looking research playbook.

• KNUCKLES Controls Floral Meristem Termination via Hormone Mo

  2026-07-09

  This study uncovers how the KNUCKLES (KNU) transcription factor precisely integrates auxin distribution and cytokinin activity to ensure the timely termination of the floral meristem in Arabidopsis. By revealing direct chromatin-level repression of key hormonal genes, the research advances mechanistic understanding of floral determinacy and developmental timing.

• Lypressin Acetate: Bridging Antidiuretic and Antiviral Resea

  2026-07-08

  Discover how Lypressin acetate, a potent lysine vasopressin analog, advances both antidiuretic and antiviral research. This article explores unique pharmacological insights and practical assay guidance not found in existing literature.

• iRGD-Modified RBC Membrane Nanocarriers Boost PDT in Neurobl

  2026-07-08

  This study presents a biomimetic drug delivery platform using iRGD-functionalized red blood cell membranes to significantly enhance photodynamic therapy (PDT) in neuroblastoma. The approach achieves improved drug encapsulation, targeted tumor penetration, and increased therapeutic efficacy—offering a refined strategy for pediatric solid tumor management.

• Regorafenib Reduces RRM2 to Suppress Melanoma Progression

  2026-07-07

  A recent iScience study uncovers how Regorafenib (BAY 73-4506) inhibits melanoma by downregulating RRM2 and disrupting ERK/E2F3 signaling. These findings provide mechanistic clarity and practical direction for targeting tumor growth, invasion, and metastasis using multikinase inhibition.

• Indole-3-pyruvic Acid Modulates Immune Balance in Rheumatoid

  2026-07-07

  This study reveals how indole-3-pyruvic acid (IPA) restores immune balance in rheumatoid arthritis (RA) by acting through the aryl hydrocarbon receptor (AhR) pathway. The findings provide evidence for IPA's immunomodulatory effects and highlight its potential as a mechanistically targeted adjunct in RA research and therapy.

• Phenothiazines Enhance Macrophage Defense via ROS and Autoph

  2026-07-06

  The reference study demonstrates that phenothiazines, including promethazine hydrochloride, markedly enhance the antibacterial capacity of macrophages by inducing both reactive oxygen species (ROS) and autophagy. These findings provide a mechanistic basis for host-directed therapies targeting intracellular pathogens, offering new strategies in immunology and inflammation research.

447 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page